NFG
Nations Financial Group’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Sell |
29,244
-252
| -0.9% | -$20.9K | 0.17% | 151 |
|
|
2025
Q1 | $2.39M | Sell |
29,496
-441
| -1% | -$35.8K | 0.18% | 147 |
|
|
2024
Q4 | $2.7M | Sell |
29,937
-426
| -1% | -$38.4K | 0.2% | 129 |
|
|
2024
Q3 | $3M | Buy |
30,363
+372
| +1% | +$36.8K | 0.22% | 111 |
|
|
2024
Q2 | $2.78M | Buy |
29,991
+324
| +1% | +$30K | 0.23% | 109 |
|
|
2024
Q1 | $2.82M | Sell |
29,667
-489
| -2% | -$46.4K | 0.24% | 103 |
|
|
2023
Q4 | $2.69M | Sell |
30,156
-295
| -1% | -$26.3K | 0.25% | 98 |
|
|
2023
Q3 | $2.22M | Sell |
30,451
-416
| -1% | -$30.4K | 0.22% | 111 |
|
|
2023
Q2 | $2.57M | Buy |
30,867
+102
| +0.3% | +$8.49K | 0.25% | 98 |
|
|
2023
Q1 | $2.34M | Buy |
30,765
+25,686
| +506% | +$1.96M | 0.25% | 105 |
|
|
2022
Q4 | $422K | Sell |
5,079
-100
| -2% | -$8.3K | 0.05% | 391 |
|
|
2022
Q3 | $411K | Buy |
5,179
+100
| +2% | +$7.94K | 0.06% | 335 |
|
|
2022
Q2 | $377K | Buy |
5,079
+60
| +1% | +$4.45K | 0.05% | 361 |
|
|
2022
Q1 | $451K | Buy |
+5,019
| New | +$451K | 0.05% | 337 |
|
|
2021
Q1 | – | Sell |
-1,484
| Closed | -$209K | – | 369 |
|
|
2020
Q4 | $209K | Buy |
+1,484
| New | +$209K | 0.06% | 309 |
|
|
2020
Q3 | – | Sell |
-1,991
| Closed | -$223K | – | 298 |
|
|
2020
Q2 | $223K | Buy |
+1,991
| New | +$223K | 0.08% | 245 |
|